Best Biopharma Outsourcing Companies in Sweden
The 59 best Biopharma Outsourcing companies in Sweden in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Personal Chemistry.
Sweden's Biopharma Outsourcing sector has 59 tracked companies and just $63M in total disclosed funding, which tells you something useful right away: this is a market built on contracted revenue, not venture spectacle. Personal Chemistry leads the directory at $50M raised, with A+ Science at $8M and BrainZell at $1M rounding out the visible funding stack. No unicorns. What there is instead is a global industry growing from $28.7B in 2024 toward $112.3B by 2032, a 5.8% CAGR driven by biologics demand and rising drug development costs that make outsourcing the rational call for sponsors of every size. The best Biopharma Outsourcing companies in Sweden ranked here reflect that structural pull, not hype cycles.
I'd note that regulatory compliance pressure is reshaping what clients actually want from CROs and CDMOs right now. Clinical trial outsourcing and operational resilience are the hot coverage themes, and Sweden's ecosystem, backed by investors like Healthcap and Almi Invest, is positioned squarely in that current. The funding numbers are modest by global standards, but the contracted-service model means the real revenue pool sits well above what any cap table discloses. So don't read the $63M figure as a ceiling.
- ResearchAndMarkets.com
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Sweden
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Personal Chemistry Medicinal and Combinatorial Chemistry | $50M | 288 mo ago | Acquired | — | 1998 | — | 14 patents Patents concentrated in electrical & electronics | — |
| 2 | A+ Science Contract research organization offering clinical, pharmacovigilance and consultant outsourcing services | $8M | 316 mo ago | Series A | Jennifer Heyno CEO | 1997 | — | — | — |
| 3 | SARomics Biostructures Provider of services for protein crystallography and structure-based drug design | $2M | 106 mo ago | Seed | Bjorn Walse Founder & CEO | 2006 | WordPress Block EditorWordPressMySQL+18 | — | — |
| 4 | BrainZell Developer of lab-grown cell based models of the human brain for drug development | $1M | 22 mo ago | Seed | Robin Pronk Co-Founder | 2020 | — | — | — |
| 5 | Quantify Research Provider of healthcare evidence and market access services | $490K | 118 mo ago | Funding Raised | — | 2011 | WordPressMySQLPHP+32 | — | — |
| 6 | InfiCure Bio Preclinical CRO specializing in anti-inflammatory and anti-fibrotic drugs | $59K | 103 mo ago | Deadpooled | Sofia Mayans CEO | 2013 | — | — | — |
| 7 | HepaPredict AB CRO focusing in the areas of drug metabolism and toxicity | $54K | 34 mo ago | Funding Raised | — | 2016 | — | — | — |
| 8 | Pelago Bioscience Assay services for use in the determination and quantification of drug-target interactions | $23K | 34 mo ago | Seed | Michael Dabrowski CEO | 2013 | WordPress Block EditorWordPressApple iCloud Mail+19 | 14 patents Thermal shift assay methods for drug-response biomarker discovery and ligand‑binding analysis | 1 launch · 1 award |
Top 12 Biopharma Outsourcing companies in Sweden
#1
Seed · Stockholm, Stockholm County · founded 2020 · 2 employees$1.5Mraised▾
Developer of lab-grown cell-based models of the human brain intended to make medicine discovery more effective and minimize the use of animals. The company uses stem cell-based models that match the human brain better than that of animals, enabling patients to have safer pharmaceuticals.
- Aug 2024Seed$1.5M
#2
Acquired · Uppsala, Uppsala County · founded 1998 · 86 employees$50.5Mraised▾
Provider of medicinal research in Organic chemistry and development in drug discovery. The company focuses on chemistry development phase of pharmaceuticals, R&D through microwave-assisted synthesis, knowledge management and reproducible methods.
#3
Series A · Stockholm, Stockholm County · founded 1997$8.2Mraised▾
Contract research organization offering clinical, pharmacovigilance and consultant outsourcing services
#4
Seed · Lund, Skane County · founded 2006 · 30 employees$2.1Mraised▾
SARomics Biostructures is a protein crystallization, protein crystallography, and structure-based drug design CRO. The platform focus on state-of-the-art industry-leading technologies for high-throughput protein crystallization and structure determination, computational chemistry, and fragment-based screening. SARomics structural biology platform and expertise in structure-based drug design are applied to a number of early-stage drug discovery projects as well as in fee for service projects for clients. The company's extensive portfolio of FastLane off-the-shelf protein structures, which include kinases, phosphatases, epigenetic targets, and many other proteins enables faster project execution substantially accelerating the drug discovery process.
- Sep 2017Grant (prize money)$608.1K
- Jan 2017Grant (prize money)$542.8K
- Apr 2016Grant (prize money)$635.9K
- Jan 2015Grant (prize money)$318.7K
#5
Funding Raised · Stockholm, Stockholm County · founded 2016 · 4 employees$53.9Kraised▾
CRO focusing in the areas of drug metabolism and toxicity
- Sep 2023Grant (prize money)$53.9K
#6
Seed · Solna, Stockholm County · founded 2013 · 43 employees$23.2Kraised▾
Assay services for use in the determination and quantification of drug-target interactions. The company offers patented Cellular Thermal Shift Assay (CETSA) for use in determination and quantification of drug-target interactions. The company delivers in situ target engagement studies to accelerate preclinical and clinical drug discovery and diagnostics development. The company offers 3 assay services CETSA Classics, western blot-based detection, CETSA HT, Plate based fluorescence detection, CETSA MS, Mass spectrometry detection of target engagement on up to 6000 proteins.
- Aug 2023Seed—
- Jan 2017Grant (prize money)$23.2K
#7
Funding Raised · Stockholm, Stockholm County · founded 2011$489.9Kraised▾
Provider of healthcare evidence and market access services. It offers services in health economics, outcomes research, real-world evidence, and market access, supporting clients in the pharmaceutical and medical device industries.
- Sep 2016Grant (prize money)$489.9K
#8
Deadpooled · Umea, Vasterbotten County · founded 2013 · 5 employees$59.5Kraised▾
InfiCure Bio is a life science company focusing on preclinical development and validation of drugs that target chronic inflammatory and fibrotic conditions. Based on a panel of in vivo models for these conditions including a proprietary model for chronic inflammation and fibrosis, they offer effect tests of anti-inflammatory and anti-fibrotic drugs. The basis of the company is a proprietary preclinical fibrosis model together with the founders’ competence in the field of inflammation/fibrosis as well as in work with pre-clinical models. The company started as a project at Umeå Biotech Incubator (UBI) in 2013. The project was initiated by Prof. Dan Holmberg and Dr. Sofia Mayans based on research conducted in the research group of Prof. Holmberg at the Universities of Umeå and Lund.The company’s preferred business model is to offer pharmaceutical companies to test their new anti-inflammatory/anti-fibrotic drugs in the unique model. The offer includes set-up, execution, analysis and reporting of results from the effect tests.
- Dec 2017Grant (prize money)$59.5K
- Oct 2017Series A—
#9
Late Stage · Matfors, Vasternorrland County · founded 1963 · 132 employees—raised▾
Developer and manufacturer of biologics
#10
Acquired · Uppsala, Uppsala County · founded 2005—raised▾
Company offering in-vivo pharmacology and toxicology services
#11
Funding Raised · Lund, Skane County · founded 2007 · 15 employees—raised▾
Redoxis is a preclinical CRO offering its services for the development of small molecules targeting molecular pathways in the immunological responses associated with autoimmune diseases. The company offers in vivo and in-vitro models for studying and developing small molecule drugs targeting autoimmunity and inflammatory conditions. Their service portfolio includes mechanism of action (MoA) evaluation, ex vivo ranking, pharmacokinetic (PK) investigation, biomarker identification, in vivo efficacy and biomarker analyses. The company offers disease models for the study of Rheumatoid Arthritis, Multiple Sclerosis, Guillain–Barre syndrome (GBS), and Systemic Lupus Erythematosus (SLE). Redoxis is developing Ncf1 mutated mice that would have increased susceptibility to various autoimmune and inflammatory conditions and can be used for preclinical studies.
#12
Acquired · Uppsala, Uppsala County · founded 1989 · 527 employees—raised▾
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development. It also offers efficient separation technologies from analysis to industrial scale and high quality medical, analytical and peptide chemistry solutions for research and commercial-scale application. The products are utilized by government agencies, academic institutions, pharmaceutical organizations, and food industry entities, among others.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Sweden
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 299 Sweden-affiliated papers.
- Swedish University of Agricultural Sciences53
- Karolinska Institutet52
- Uppsala University33
- Science for Life Laboratory29
- University of Gothenburg28
- Messenger RNA1→7
- Transcription (linguistics)1→4
- Gene4→5
- Gene1→5
- Antibody1→5
- Antibiotic resistance3
- Antibiotics3
- Agriculture3
- Production (economics)3
- Antimicrobial2
Where biotechnology is researched across Sweden
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.